Clinical Trial Update: Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer [NA]

View source ↗

Summary

Clinical trial evaluating HyperArc stereotactic body radiation therapy for recurrent head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Recurrent Head and Neck Carcinoma | NA | Status: COMPLETED